MENU
+Compare
RVNC
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$3.68
Change
+$0.41 (+12.54%)
Capitalization
384.15M

RVNC Revance Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs

Industry Biotechnology
RVNC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RVNC with price predictions
Jan 08, 2025

RVNC sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for RVNC moved below the 200-day moving average on December 23, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where RVNC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVNC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RVNC broke above its upper Bollinger Band on January 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on RVNC as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RVNC just turned positive on December 19, 2024. Looking at past instances where RVNC's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RVNC advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RVNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). RVNC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (1.386) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RVNC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVNC is expected to report earnings to fall 44.30% to -20 cents per share on March 04

Revance Therapeutics RVNC Stock Earnings Reports
Q4'24
Est.
$-0.21
Q3'24
Missed
by $0.10
Q2'24
Est.
$-0.36
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.03
The last earnings report on November 07 showed earnings per share of -37 cents, missing the estimate of -27 cents. With 11.24M shares outstanding, the current market capitalization sits at 384.15M.
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBSRX50.390.45
+0.90%
Neuberger Berman Sustainable Equity Inv
VYSYX10.830.05
+0.46%
Voya Small Company A
GABBX17.24N/A
N/A
Gabelli Dividend Growth AAA
SSGSX47.56N/A
N/A
Victory Sycamore Small Company Opp A
AVEEX11.48N/A
N/A
Avantis® Emerging Markets Equity Instl

RVNC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RVNC has been loosely correlated with AXON. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RVNC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVNC
1D Price
Change %
RVNC100%
+12.54%
AXON - RVNC
39%
Loosely correlated
+1.37%
HRMY - RVNC
39%
Loosely correlated
+1.32%
GOSS - RVNC
35%
Loosely correlated
-3.81%
ARRY - RVNC
34%
Loosely correlated
-0.14%
AVTE - RVNC
33%
Loosely correlated
+6.17%
More